New Antigens Against Glioblastoma (INAAG)

Institute of Hospitalization and Scientific Care (IRCCS)

Status: Not yet enrolling

Conditions: Glioblastoma Multiforme

Study type: Observational

Funder types: Other

Identifiers

NCT05917821

5866

Details and patient eligibility

About

In this study the investigators will select and develop potential therapeutic monoclonal antibodies (mAbs) for glioblastoma (GB). Activities include tissue microarray (TMA) to test monoclonal antibodies specificity and target distribution, selection of glioblastoma specific functional monoclonal antibodies, identification of candidate targets.

Enrollment: 120 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• age > 18 years;
• Written informed consent

Exclusion criteria

• Not-availability of informed consent